| Colinz Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.07 | 0.05 | 0.05 | 0.10 | 0.10 |
| Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.71 | 3.68 | 3.54 | 2.92 | 2.80 |
| Fixed Assets | 1.04 | 1.14 | 1.09 | 1.01 | 0.91 |
| Inventory | 8.01 | 7.85 | 7.65 | 6.39 | 4.19 |
| Debtors | 8.59 | 7.07 | 6.11 | 5.55 | 4.42 |
| Interest Cover Ratio | 16.50 | 17.25 | 13.00 | 7.00 | 3.78 |
| PBIDTM (%) | 12.10 | 11.66 | 10.91 | 10.90 | 8.60 |
| PBITM (%) | 10.11 | 9.82 | 9.09 | 8.03 | 5.52 |
| PBDTM (%) | 11.49 | 11.10 | 10.21 | 9.76 | 7.14 |
| CPM (%) | 9.65 | 8.82 | 8.25 | 7.75 | 6.49 |
| APATM (%) | 7.66 | 6.97 | 6.43 | 4.88 | 3.41 |
| ROCE (%) | 6.72 | 7.70 | 7.82 | 6.78 | 4.36 |
| RONW (%) | 5.43 | 5.73 | 5.81 | 4.54 | 2.97 |